Bank of New York Mellon Corp Cuts Stake in Dolby Laboratories $DLB

Bank of New York Mellon Corp cut its holdings in shares of Dolby Laboratories (NYSE:DLB) by 0.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,549,482 shares of the electronics maker’s stock after selling 35,447 shares during the quarter. Bank of New York Mellon Corp owned 0.06% of Dolby Laboratories worth $401,616,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. First Horizon Corp bought a new position in shares of Dolby Laboratories during the 3rd quarter valued at $25,000. Allworth Financial LP boosted its position in Dolby Laboratories by 590.4% during the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock valued at $37,000 after buying an additional 431 shares during the period. Mather Group LLC. bought a new position in shares of Dolby Laboratories during the third quarter valued at about $38,000. Ameritas Advisory Services LLC purchased a new position in shares of Dolby Laboratories in the second quarter worth about $48,000. Finally, Atlantic Union Bankshares Corp purchased a new position in shares of Dolby Laboratories in the second quarter worth about $50,000. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Dolby Laboratories News Summary

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Q1 beat on top‑ and bottom‑line estimates — Dolby reported $1.06 EPS vs. a ~$0.90 consensus and revenue of $346.7M vs. ~$341M, showing the quarter topped Street forecasts. Read More.
• Positive Sentiment: Management tone constructive — CEO Kevin Yeaman described a “good start to the fiscal year” and expressed confidence in growth opportunities, which supports near‑term sentiment. Read More.
• Neutral Sentiment: Analyst coverage is mixed but skewed positive — several firms maintain buy/outperform ratings and price targets well above the current price (median target cited ~$87.50), giving upside narrative but not immediate catalyst certainty. Read More.
• Neutral Sentiment: Company provided investor materials and call recording/press release for follow‑up — useful for investors who want to verify guidance and metric details. Read More.
• Negative Sentiment: Profitability and cash‑flow weaker YoY — operating profit, net income and gross profit declined year‑over‑year and cash from operations was reported negative, highlighting margin pressure and near‑term cash concerns that could limit upside. Read More.
• Negative Sentiment: Insider selling and recent analyst downgrades/1‑year low headlines add downside risk — heavy insider sales and at least one noted downgrade contributed to recent negative attention. Read More.

Dolby Laboratories Stock Performance

Shares of DLB stock opened at $62.89 on Friday. Dolby Laboratories has a fifty-two week low of $60.14 and a fifty-two week high of $89.66. The firm has a market cap of $6.01 billion, a P/E ratio of 23.91 and a beta of 0.88. The business’s 50 day moving average price is $65.14 and its 200-day moving average price is $68.95.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. The company had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The firm’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, equities analysts predict that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend was Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s payout ratio is presently 54.75%.

Wall Street Analysts Forecast Growth

DLB has been the subject of several analyst reports. Rosenblatt Securities restated a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a report on Thursday, January 22nd. Barrington Research dropped their price objective on Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Monday. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Monday, January 5th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 29th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, Dolby Laboratories has an average rating of “Moderate Buy” and an average target price of $90.75.

Insider Activity at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 36,699 shares of the business’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $66.91, for a total transaction of $2,455,530.09. Following the transaction, the chief executive officer owned 114,725 shares in the company, valued at $7,676,249.75. The trade was a 24.24% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mark Andrew Sherman sold 9,109 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $66.73, for a total transaction of $607,843.57. Following the completion of the sale, the executive vice president owned 73,054 shares of the company’s stock, valued at $4,874,893.42. This trade represents a 11.09% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 137,120 shares of company stock worth $9,184,809 over the last ninety days. Corporate insiders own 37.93% of the company’s stock.

Dolby Laboratories Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.